ALK and non-small cell lung carcinoma: In Turkey, ALK rearrangements in NSCLC are reported to range from 3.4% to 8.3%, and ROS1 rearrangements from 0.4% to 1.9%, with RET and NTRK rearrangements being even less frequent [2].